SCHEMBL3345266

SCHEMBL3345266

Nc1ccsc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL25183750 0.97
Bromide SCHEMBL18047930 0.97
SCHEMBL18317912 0.69 ALDH1A1 (0.54)
SCHEMBL134132 0.69
SCHEMBL225071 0.69
SCHEMBL18099186 0.69 CES1 (0.39)
SCHEMBL3715393 0.69 CES1 (0.39)
SCHEMBL7998906 0.67
SCHEMBL19114718 0.67
SCHEMBL20273158 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101015-A1 HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2025-03-27 US disclosed
US-20250084076-A1 HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2025-03-13 US disclosed
US-12172993-B2 Heterocyclic kinase inhibitors and uses thereof IOMX THERAPEUTICS AG (DE) 2024-12-24 US disclosed
EP-3400253-B1 DITHIOPHENETHIADIAZOLE SEMICONDUCTORS AND RELATED DEVICES FLEXTERRA INC (US) 2023-10-04 EP disclosed
EP-3814331-B9 NOVEL LXR MODULATORS WITH BICYCLIC CORE MOIETY ORSOBIO INC (US) 2023-08-09 EP disclosed
WO-2023085415-A1 COMPOUND, ANGIOTENSIN-II TYPE 1 RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION 株式会社アークメディスン 2023-05-19 WO disclosed
US-20210387982-A1 HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2021-12-16 US disclosed
CN-112955447-A Heterocyclic kinase inhibitors and uses thereof 艾欧麦克斯治疗股份公司 2021-06-11 CN disclosed
US-20210147398-A1 NOVEL LXR MODULATORS WITH BICYCLIC CORE MOIETY PHENEX-FXR GMBH (DE) 2021-05-20 US disclosed
EP-3013802-B1 N-CYCLOALKYL-N-[(BICYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-14 EP disclosed
WO-2016144846-A1 PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY MERCK SHARP & DOHME CORP. (US) 2016-09-15 WO disclosed
EP-3046156-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT Konica Minolta Holdings, Inc. (JP) 2016-07-20 EP disclosed
EP-2940013-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND UBE Industries, Ltd. (JP) 2015-11-04 EP disclosed
WO-2014104372-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND 宇部興産株式会社 (JP) 2014-07-03 WO disclosed
EP-2393781-B1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
WO-2010086089-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2010-08-05 WO disclosed
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed
US-6664297-B1 Impeding formation of amyloid fibers or dissolving existing fibers in mammals UNIVERSIDADE FEDERAL DO RIO DE JANEIRO (BR) 2003-12-16 US disclosed
WO-2001028546-A1 INHIBITION OF AMYLOIDOSES BY USING AROMATIC OR HETEROAROMATIC COMPOUNDS SUBSTITUTED BY ELECTRON-WITHDRAWING GROUPS UNIVERSIDADE FEDERAL DO RIO DE JANEIRO (BR) 2001-04-26 WO disclosed